Open AccessBacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics
Author(s) -
Yrvin León,
Christina S. Faherty
Publication year - 2021
Publication title -
current opinion in infectious diseases/current opinion in infectious diseases, with evaluated medline
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.68
H-Index - 103
eISSN - 1080-7861
pISSN - 0951-7375
DOI - 10.1097/qco.0000000000000772
Subject(s) - phage therapy , bacteriophage , crispr , antimicrobial , dysbiosis , bacterial virus , antibiotic resistance , biology , bacteria , microbiology and biotechnology , antibiotics , computational biology , virology , escherichia coli , microbiome , bioinformatics , genetics , gene
Alarming rates of antibiotic resistance in bacteria and gastrointestinal dysbiosis associated with traditional antimicrobial therapy have led to renewed interests in developing bacteriophages as novel therapeutics. In this review, we highlight some of the recent advances in bacteriophage therapeutic development targeting important enteropathogens of the gastrointestinal tract.